Efficacy and Safety of Alogliptin in Subjects With Type 2 Diabetes

Clinical trial NCT00286455 · COMPLETED

Trial details

NCT number: NCT00286455
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus

Start date: 2006-02-01
Primary completion: 2007-07-01
Enrollment: 329

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.